Page last updated: 2024-08-24

aptiganel and Brain Ischemia

aptiganel has been researched along with Brain Ischemia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aronowski, J; Grotta, JC; Palusinski, R; Piriyawat, P; Strong, R; Zhao, X1
Barber, PA; Buchan, AM; Hill, MD; Hoyte, L1
Aronowski, J; Grotta, JC; Ostrow, P; Samways, E; Strong, R; Zivin, JA1
Lees, KR1
Kawasaki-Yatsugi, S; Shimizu-Sasamata, M; Yamaguchi, T; Yatsugi, S1
Albers, GW; Goldstein, LB; Hall, D; Lesko, LM1
Albers, GW; Goldstein, LB1

Reviews

2 review(s) available for aptiganel and Brain Ischemia

ArticleYear
The rise and fall of NMDA antagonists for ischemic stroke.
    Current molecular medicine, 2004, Volume: 4, Issue:2

    Topics: Animals; Brain Ischemia; Cell Survival; Disease Models, Animal; Excitatory Amino Acid Antagonists; Guanidines; Humans; Indoles; Ischemia; N-Methylaspartate; Neurons; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate; Stroke

2004
Cerestat and other NMDA antagonists in ischemic stroke.
    Neurology, 1997, Volume: 49, Issue:5 Suppl 4

    Topics: Brain Ischemia; Cerebrovascular Disorders; Excitatory Amino Acid Antagonists; Guanidines; Humans; Receptors, N-Methyl-D-Aspartate

1997

Trials

1 trial(s) available for aptiganel and Brain Ischemia

ArticleYear
Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.
    JAMA, 2001, Dec-05, Volume: 286, Issue:21

    Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Female; Guanidines; Humans; Male; Middle Aged; Neuroprotective Agents; Stroke; Survival Analysis; Time Factors

2001

Other Studies

4 other study(ies) available for aptiganel and Brain Ischemia

ArticleYear
Caffeinol at the receptor level: anti-ischemic effect of N-methyl-D-aspartate receptor blockade is potentiated by caffeine.
    Stroke, 2010, Volume: 41, Issue:2

    Topics: Animals; Brain Ischemia; Caffeine; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Ethanol; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Guanidines; Male; N-Methylaspartate; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Phosphodiesterase Inhibitors; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Time Factors; Treatment Outcome

2010
Graded bioassay for demonstration of brain rescue from experimental acute ischemia in rats.
    Stroke, 1994, Volume: 25, Issue:11

    Topics: Acute Disease; Animals; Biological Assay; Brain; Brain Ischemia; Guanidines; Hypothermia, Induced; Male; Neuroprotective Agents; Rats; Rats, Inbred SHR; Receptors, N-Methyl-D-Aspartate; Staining and Labeling; Tetrazolium Salts; Time Factors

1994
Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats.
    The Journal of pharmacy and pharmacology, 1998, Volume: 50, Issue:8

    Topics: Animals; Brain Ischemia; Cerebral Arteries; Dose-Response Relationship, Drug; Guanidines; Injections, Intravenous; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Time Factors

1998
Patient safety in trials of therapy for acute ischemic stroke.
    JAMA, 2002, Feb-27, Volume: 287, Issue:8

    Topics: Brain Ischemia; Clinical Trials as Topic; Guanidines; Humans; Neuroprotective Agents; Safety; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator

2002
chemdatabank.com